Contemporary Immunosuppression in Simultaneous Heart–Kidney Transplantation: A United Network for Organ‐Sharing Database Analysis

Key Points

• To evaluate the outcomes of different immunosuppression induction strategies in simultaneous heart-kidney transplant (SHKT) recipients.
• Data analysis from the United Network for Organ Sharing (UNOS) database.
• Comparison of 1-year outcomes across various induction strategies.
• Specific focus on patients receiving basiliximab.
• 1-year outcomes are similar across different induction strategies in SHKT recipients.
• Basiliximab is effective for standard-risk SHKT recipients.

Abstract